Home > Boards > US OTC > Medical - Equipment > Ozop Surgical Corp. (OZSC)

Revenue ramp-up underway with pathway to operating profit

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
dpm58 Member Profile
 
Followed By 41
Posts 2,904
Boards Moderated 0
Alias Born 12/15/09
160x600 placeholder
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 12/9/2019 5:18:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/6/2019 5:11:54 PM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 11/27/2019 5:21:14 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2019 4:58:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/31/2019 4:39:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/15/2019 4:14:19 PM
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 10/15/2019 8:02:20 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/7/2019 5:15:09 PM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 10/4/2019 4:14:27 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/2/2019 6:00:57 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/24/2019 4:02:22 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 9/19/2019 5:18:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/17/2019 8:07:03 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 9/16/2019 8:52:49 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/26/2019 9:04:41 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/23/2019 5:23:42 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/19/2019 2:49:08 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 8/15/2019 4:07:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/30/2019 4:27:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/10/2019 5:14:24 PM
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 6/28/2019 10:35:02 AM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 6/14/2019 4:05:17 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/11/2019 5:12:05 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/31/2019 4:48:33 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/22/2019 5:20:39 PM
dpm58   Wednesday, 10/16/19 03:14:45 PM
Re: None
Post # of 1740 
Revenue ramp-up underway with pathway to operating profit

WEST PALM BEACH, FL, Oct. 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Ozop Surgical Corp. (OZSC), a provider of premium surgical devices in the rapidly growing field of minimally invasive spine surgery (“Ozop” or the “Company”), today released the following corporate update on its recent progress and current developments. Ozop believes the license agreement with Spinal Resources, Inc. is exceeding Company expectations.

Some of the specific developments include:

· 3 new surgeons currently using its licensed products, with 2 more expected to schedule cases before year end.

· 2 new Distributors in the contract finalization stage, ramp up expected to start by year end.

· 3 hospital contracts, including one national agreement, in the finalization stage. Cases starting upon approval possibly as soon as December.

· 3 new product introductions, the first, a proprietary MIS system before the end of year.

· First member of its surgeon advisory board has joined, more updates to follow.

Michael Chermak, Chief Executive Officer of OZOP, commented, “Our primary objective is to achieve operational profitability at the earliest moment possible. Our path to this goal will be accomplished by a combination of maximizing current sales opportunities and reducing overhead wherever possible, and investing in inventory and product development to support our growing sales pipeline.”

About Ozop Surgical Corp.

Ozop Surgical, Corp. (www.ozopsurgical.com) invents, designs, develops, manufactures and distributes innovative endoscopic instruments, surgical implants, instrumentation, devices and related technologies, focused on spine, neurological and pain management procedures and specialties. Our focus is on economically disrupting the market with clinically equivalent or superior existing and new products resulting in immediate and significant savings for providers, payors and consumers. For more information please visit www.ozopsurgical.com.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist